Promising Trial in Pancreatic Cancer Enrolls First Patient
Promising Trial in Pancreatic Cancer Enrolls First Patient April 25, 2023 BRUSSELS – The first patient entered the STEREOPAC trial, in Belgium. The trial is testing a novel strategy in the treatment of patients with pancreatic cancer. The Anticancer Fund and the Rising Tide Foundation for Clinical Cancer Research co-funded this unique trial to address …
Promising Trial in Pancreatic Cancer Enrolls First Patient Read More »